Ranbaxy to sell generic anti-depression drug in US Ranbaxy expects the product to be available in the US in Q1 2013 Published: March 06, 2013 14:24 IANS The recent fall in the stock price is mainly due to bad news about the company in recent times. Things should start improving after three months as the stock bottoms out. Cash rich Japanese parent will support Ranbaxy and the company will offer decent returns. Investors can start accumulating the stock in range Rs 200 – 220. SUN PHARMACEUTICAL Sun pharma has been getting rejections from 505-510 level many times 1.if the stock is able to give the closing above this level then it may touch 540-550 easily 2. Look at the volumes it has been rising from last 1 week, again a sign of bullishness If you want me to do such detailed analysis, please comment on the same and Ranbaxy’s shares on the BSE closed at Rs 351.55, up 1.36% from Wednesday’s close of Rs 346.85. During the quarter, emerging markets contributed 54% to total sales, and grew by 44%, while developed markets contributed 40% to the total sales, and grew by 16%. Business News- Read Latest Financial news, Stock/Share Market News, Economy News, Business News on The Economic Times. Find IPO Analysis, Mutual Funds Trends & Analysis, Gold Rate, Real Estate & more.
[index]          
Pharmaceutical giant Ranbaxy Laboratories' ex-promoters Shivinder Singh, his older brother Malvinder Singh and three others have been sent to four-day police custody in a Rs. 740-crore fraud case ... Economic Times Gogoi takes oath amid protests, walkout in Rajya Sabha; Rakesh Mohan Chaturvedi; Mar 20, 2020 Kurian Joseph hits out Gogoi for taking RS route; Samanwaya Rautray; Mar 20, 2020 Breaking News: ਅਦਾਲਤ ਨੇ Dera Beas Head Gurinder Dhillion ਤੋਂ ਮੰਗਿਆ ਸਪੱਸ਼ਟੀਕਰਨ Daiichi-Ranbaxy Scam - Duration: 25:37. News18 Punjab/Haryana ... Zak Crawley hits 76 as Visitors Gain Upper Hand England v West Indies 1st Test Day 4 2020 - Duration: 5:06. England & Wales Cricket Board 1,950,380 views. New Navbharat Times नवभारत टाइम्स Recommended for you 11:20 Video: How Singh brothers blew $3.2 bn and lost control over Fortis, Religare in less than a decade - Duration: 6:22.